Table 2 Treatment regimens and patient-reported and objectively measured asthma medication adherence in 178 patients attending a university hospital outpatient clinic
From: Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma
Treatment and Adherence | N (%), Mean (SD) |
|---|---|
ICS Prescribed Dose | |
Low Dose | 66 (37.1%) |
Moderate Dose | 71 (39.9%) |
High Dose | 41 (23.0%) |
Dual ICS Therapy | 32 (18.0%) |
GINA 2020 Step | |
Step 2 | 15 (8.4%) |
Step 3 | 60 (33.7%) |
Step 4 | 62 (34.8%) |
Step 5 | 41 (23.0%) |
Biologic Therapy | 3 (1.7%) |
Maintenance Oral Corticosteroids | 6 (3.4%) |
Annual SABA Use (Doses) | 255 (445) |
of which > 600 doses/yr | 32 (18.0%) |
Foster Score | 94.0% (19.0%) |
of which 100% | 156 (87.6%) |
Inhaled Corticosteroid MPR | 0.54 (0.25) |
Once-daily ICS MPR (n = 19) | 67.0% (13.1%) |
Twice-daily ICS MPR (n = 127) | 53.4% (25.2%, p = 0.05*) |
Dual ICS MPR (n = 32) | 43.9% (26.0%, p = 0.02*) |
ICS Adherence | |
80% or above | 30 (16.9%) |
Below 80% | 148 (83.1%) |